Key Points of Vaidyaratnam Group Revenue Growth & IPO 2030 News:
- Vaidyaratnam, a Thrissur-based ayurveda group, aims to close the current fiscal year with Rs 240 crore in revenue and double that by 2030 when they plan to go public.
- The company follows the holistic Ashtavaidya tradition, which covers eight areas of healthcare.
- In the previous fiscal year, the company recorded a revenue of Rs 220 crore, with Rs 170 crore coming from products/medicines and the rest from services.
- Vaidyaratnam plans to expand by entering new categories of treatment like infertility, sports, and lifestyle diseases, and launching new medical products, especially in the nutraceuticals segment.
- The company plans to expand geographically, with a focus on Jaipur, Kolhapur, and Pune in Maharashtra, and the major cities of Andhra Pradesh and Telangana.
- The group emphasizes the importance of an integrated and holistic system of healthcare, with a special focus on treating hypertension, insomnia, and irritable bowel syndrome among the younger generation.
- The company plans to take the PE route to raise capital if their expansion plans get moving as planned.
- The group has signed a deal with the 100-bedded Vrindhavan ayurveda hospital in Baddi in Himachal and is close to inking an agreement with the Saudi government to set up a 100-bedded ayurveda hospital in Riyadh.
Details of Vaidyaratnam Group Revenue Growth & IPO 2030 News:
Thrissur-based ayurveda group Vaidyaratnam aims to close the current fiscal year with Rs 240 crore in revenue and double that by 2030 when they plan to go public.
The 99-year-old entity follows the holistic Ashtavaidya tradition and is the only ayurveda group that does so. The company recorded a revenue of Rs 220 crore, with Rs 170 crore coming from products/medicines and the rest from services in the previous fiscal year.
The group plans to expand by entering new categories of treatment like infertility, sports and lifestyle diseases, and launching new medical products, especially in the nutraceuticals segment. They will focus on research and development, expanding the network, and entering the nutraceuticals segment. The group has already entered infertility and maternal care and launched an institute of fertility and maternal care earlier this year to extend its knowledge base to new areas.
Vaidyaratnam plans to expand geographically, with a focus on Jaipur, Kolhapur, and Pune in Maharashtra, and the major cities of Andhra Pradesh and Telangana. The company also aims to enter the area of sports medicine in a big way.
The group emphasizes the importance of an integrated and holistic system of healthcare, with a special focus on treating hypertension, insomnia, and irritable bowel syndrome among the younger generation. Vaidyaratnam will focus on treatment and prescription-based medicines, ruling out entering the wellness segment, as their expertise lies in delivering quality treatment and medicines.
The doctors plan to take the company public after reaching their top-line target and may also tap the PE route to raise capital if their expansion plans get moving as planned. Vaidyaratnam is entering into agreements with farmers in other states to ensure the supply of medicinal plants and is looking at entering into operations and management contracts with other ayurveda facilities.
The group has already signed a deal with the 100-bedded Vrindhavan ayurveda hospital in Baddi in Himachal and is close to inking an agreement with the Saudi government to set up a 100-bedded ayurveda hospital in Riyadh. The group runs a NABH-accredited 100-bed facility at the headquarters, along with a 150-bed medical college in the same location, which will go up to 450 by 2030. The manufacturing side of the company will increase the capacity of its three units in Thrissur and neighbouring Tamil Nadu.
The Ashtavaidya system, based on the Ashtangahridayam, a classic Sanskrit treatise on healthcare, covers eight areas of Kaya, bala, graham, urdhvanga, shalya, damshtra, jara, and vrisha.
About Vaidyaratnam Group:
Located in Thaikkattussery, near Ollur in Thrissur, Kerala, Vaidyaratnam Oushadhasala is an Ayurvedic Pharmaceutical company managed by the Thaikkattusseri Eledathu Thaikkattu Family, which is one of the Ashtavaidya families of Kerala. Vaidyaratnam operates a NABH-accredited nursing home called Vaidyaratnam Nursing Home, as well as an Ayurvedic Medical College. In addition, Vaidyaratnam has two ISO-certified manufacturing plants in Thrissur and one in Pollachi, along with an R&D center located in Thaikkattussery, Thrissur, Kerala.
For More Latest News Click Here
